Van Cutsem E, Snoeck R, Van Ranst M, Fiten P, Opdenakker G, Geboes K, Janssens J, Rutgeerts P, Vantrappen G, de Clercq E
Department of Gastroenterology, Katholieke Universiteit Leuven, Belgium.
J Med Virol. 1995 Feb;45(2):230-5. doi: 10.1002/jmv.1890450221.
Human papillomaviruses (HPV) are associated with benign lesions and show specificity towards the location or tissues that they infect. HPVs are responsible for warts. Among more than 60 different HPV types known to occur in humans, a strong association has been found between types 16 and 18 and cervical cancer, and such an association is also suspected for types 31, 33, 35, 45, 51, 52, and 56. We describe the effects of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine (HPMPC), following local intratumoral injection, in a 69-year-old woman with hypopharyngeal and esophageal papillomatous lesions, polymerase chain reaction (PCR) positive for HPV types 16 and 18, that relapsed after surgery and that also failed to respond to Nd-Yag laser photocoagulation and alpha-interferon treatment (6 x 10(6) U five times a week for 4 weeks followed by three times a week for 2 months). HPMPC was given at 1.25 mg/kg, with a sclerosing needle, through the biopsy channel of a video-endoscope, directly into the tumor, from March until July 1993 at seven different occasions. The first four injections were given at an interval of 1 week at the level of the hypopharynx. The next three injections were given at an interval of 3 to 5 weeks. During the fourth to the seventh session, half of the dose was injected into the hypopharyngeal and the other half into the esophageal tumor. Three further injections of HPMPC were administered at the level of the esophageal tumor in September 1993 with 2-week intervals. After HPMPC treatment, the lesions became smaller and flat until they completely disappeared.(ABSTRACT TRUNCATED AT 250 WORDS)
人乳头瘤病毒(HPV)与良性病变相关,且对其所感染的部位或组织具有特异性。HPV可引发疣。在已知的60多种可感染人类的不同HPV类型中,已发现16型和18型与宫颈癌之间存在紧密关联,31、33、35、45、51、52和56型也疑似存在这种关联。我们描述了在一名69岁患有下咽和食管乳头状瘤病变的女性患者中,局部瘤内注射(S)-1-(3-羟基-2-膦酰甲氧基丙基)胞嘧啶(HPMPC)的效果。该患者HPV 16型和18型聚合酶链反应(PCR)呈阳性,手术后复发,且对Nd-Yag激光光凝和α干扰素治疗(6×10⁶U,每周5次,共4周,随后每周3次,持续2个月)均无反应。1993年3月至7月期间,通过视频内窥镜的活检通道,使用硬化针将HPMPC以1.25mg/kg的剂量直接注射到肿瘤中,共进行了7次不同的注射。前4次注射在下咽水平每隔1周进行一次。接下来的3次注射间隔3至5周。在第4至7次注射期间,一半剂量注射到下咽肿瘤,另一半注射到食管肿瘤。1993年9月,在食管肿瘤部位又进行了3次HPMPC注射,间隔2周。HPMPC治疗后,病变逐渐变小变平直至完全消失。(摘要截取自250字)